Shanxi Medical University
Also known as: Fenyang Hospital Affiliated to Shanxi Medical University | First Hospital of Shanxi Medical University | Second Hospital of Shanxi Medical University | Shanxi Dayi Hospital | Shanxi Eye Hospital | Shanxi Medical University | Shanxi Province Cancer Hospital | Shanxi Provincial Maternity and Children's Hospital | Shanxi Provincial People's Hospital | Shanxi provincial peple's hospital | Shanxi Traditional Chinese Medical Hospital | Suping Wang | Taiyuan Central Hospital of Shanxi Medical University | The First Affiliated Hospital of Shanxi Medical University | The First Affiliated Hospital of Shanxi University of Traditional Chinese Medicine | The Tuberculosis Prevention and Treatment Hospital of Shanxi Province | Tumor Hospital of Shanxi Province
Highest phase reached
Phase 4
First clinical trial
Jun 1, 2006Last known activity
Feb 1, 2026
Timeline
1910s
- Jan 1, 1919
Shanxi Medical University— Founded
Drugs by trial phase (164 distinct, 113 trials)
Phase 4 (64 own, 0 via acquisition)
Phase 3 (30 own, 0 via acquisition)
Phase 2 (35 own, 0 via acquisition)
Phase 1 (6 own, 0 via acquisition)
Other trials (29 own, 0 via acquisition)
Indications
Studied for
- Adenocarcinoma
- Adenocarcinoma of Lung
- Brain Neoplasms
- Breast Neoplasms
- Carcinoma
- Carcinoma, Hepatocellular
- Carcinoma, Squamous Cell
- Cardiomyopathies
- Cardiomyopathy, Dilated
- Cerebral Infarction
- Cognitive Dysfunction
- Colorectal Neoplasms
- Delirium
- Depression
- Depressive Disorder
- Disease
- Embolism
- Esophageal Squamous Cell Carcinoma
- Fibrosis
- Gout
- Heart Failure
- Heart Failure, Systolic
- Hepatitis
- Hepatitis A
- Hepatitis B
- Hip Fractures
- Infarction
- Infertility
- Infertility, Female
- Kidney Diseases
- Liver Cirrhosis
- Lymphoma
- Lymphoma, Extranodal NK-T-Cell
- Lymphoma, T-Cell
- Major Depressive Disorder
- Multiple Myeloma
- Nasal Polyps
- Neoplasm Metastasis
- Neoplasms, Plasma Cell
- Neoplasms, Second Primary
- Pneumonia
- Postoperative Complications
- Pulmonary Embolism
- Purpura
- Purpura, Thrombocytopenic
- Purpura, Thrombocytopenic, Idiopathic
- Renal Insufficiency, Chronic
- Schizophrenia
- Sinusitis
- Stroke
- Thrombocytopenia
- Thromboembolism
- Thrombosis
- Tuberculosis
- Tuberculosis, Pulmonary
Recent trials (50)
- NCT07276919CollaboratorPhase 4Feb 1, 2026
- NCT07239674CollaboratorPhase 3Nov 30, 2025
- NCT07280663Sponsor investigatorEarly Phase 1Oct 9, 2025
- NCT07280663Lead sponsorEarly Phase 1Oct 9, 2025
- NCT07075250CollaboratorPhase 4Sep 1, 2025
- NCT07083375CollaboratorPhase 2Aug 1, 2025
- NCT06897046OfficialPhase 2Jul 30, 2025
- NCT07012902Sponsor investigatorEarly Phase 1Jun 12, 2025
- NCT07012902Lead sponsorEarly Phase 1Jun 12, 2025
- NCT06990763OfficialN/AJun 1, 2025
- NCT06990763Lead sponsorN/AJun 1, 2025
- NCT06990763Sponsor investigatorN/AJun 1, 2025
- NCT06968429CollaboratorN/AMay 31, 2025
- NCT06808841Lead sponsorN/AFeb 5, 2025
- NCT06808841Sponsor investigatorN/AFeb 5, 2025
Details
- Founded
- Taiyuan, CN Jan 1, 1919
- Last known activity
- Feb 1, 2026